These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7153515)

  • 21. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
    Winsnes R; Sesardic D; Daas A; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined diphtheria-tetanus immunization of adults.
    Trinca JC
    Med J Aust; 1975 Oct; 2(14):543-6. PubMed ID: 1196209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents.
    Tran Minh NN; He Q; Ramalho A; Kaufhold A; Viljanen MK; Arvilommi H; Mertsola J
    Pediatrics; 1999 Dec; 104(6):e70. PubMed ID: 10586004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous immunization with B.C.G., diphtheria-tetanus, and oral poliomyelitis vaccines in children aged 13-14.
    Galbraith NS; Crosby G; Barnes JM; Fernandes R
    Br Med J; 1971 Apr; 2(5755):193-7. PubMed ID: 5575951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diphtheria immunization in adolescents and adults with reduced doses of adsorbed diphtheria toxoid.
    Feery BJ; Benenson AS; Forsyth JR; Menser MA; Minty DW
    Med J Aust; 1981 Feb; 1(3):128-30. PubMed ID: 7219283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions.
    Golaz A; Hardy IR; Glushkevich TG; Areytchiuk EK; Deforest A; Strebel P; Wharton M; Sutter RW
    J Infect Dis; 2000 Feb; 181 Suppl 1():S203-7. PubMed ID: 10657215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of humoral immunity to tetanus and diphtheria in hematopoietic stem cell transplant recipients after post-transplant immunization.
    Škovránková J; Petráš M
    Pediatr Blood Cancer; 2012 Nov; 59(5):908-13. PubMed ID: 22514148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined vaccine against tetanus, diphtheria and polio. A randomized controlled study of immunogenicity and tolerance].
    Banzhoff A; Donner-Banzhoff N; Schwenke C; Girgsdies OE; Jilg W
    Fortschr Med Orig; 2001 Jan; 118(4):169-72. PubMed ID: 11217682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered.
    Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Germino K
    J Infect Dis; 2001 Nov; 184(10):1293-9. PubMed ID: 11679918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The kinetics of vaccine antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogeneic and autologous bone marrow transplantation and revaccination. 3: The kinetics of vaccine antibodies against tetanus toxoid and diphtheria toxoid after allogeneic and autologous bone marrow transplantation and combined revaccination against diphtheria and tetanus].
    Prager J; Baumert A; Thilo W; Hermann J; Fuchs D; Sauerbrey A; Zintl F
    Kinderarztl Prax; 1992 Nov; 60(8):230-8. PubMed ID: 1469826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
    Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
    Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a single dose of diphtheria toxoid among adults in the Republic of Georgia, 1995: immunogenicity and adverse reactions.
    Khetsuriani N; Music S; Deforest A; Sutter RW
    J Infect Dis; 2000 Feb; 181 Suppl 1():S208-12. PubMed ID: 10657216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and safety of the new reduced-dose tetanus-diphtheria vaccine in healthy Korean adolescents: A comparative active control, double-blind, randomized, multicenter phase III study.
    Han SB; Rhim JW; Shin HJ; Kim SY; Kim JH; Kim HH; Lee KY; Kim HM; Choi YY; Ma SH; Kim CS; Kim DH; Ahn DH; Kang JH
    J Microbiol Immunol Infect; 2017 Apr; 50(2):207-213. PubMed ID: 26055693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IMMUNOGENICITY AND SAFETY OF QUINVAXEM® (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE.
    Huu TN; Phuong NT; Toan NT; Thang HV
    Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):753-63. PubMed ID: 26867396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
    Someya S; Mizuhara H; Murata R; Kurokawa M
    Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of tetanus-diphtheria toxoids (Td) among Ukrainian adults: implications for diphtheria control in the Newly Independent States of the Former Soviet Union.
    Sutter RW; Hardy IR; Kozlova IA; Tchoudnaia LM; Gluskevich TG; Marievsky V; Deforest A; Wharton M
    J Infect Dis; 2000 Feb; 181 Suppl 1():S197-202. PubMed ID: 10657214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of adsorbed diphtheria-tetanus (DT) toxoid containing different doses of antigens in booster immunizations of children].
    Egor'kov NA; Moksimova NM; Platonova TV; Chebotareva SV; Lobanova AN
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):47-52. PubMed ID: 2800793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children.
    Scheifele DW; Meekison W; Grace M; Barreto L; Carter AO; Mitchell L; Farley J
    CMAJ; 1991 Sep; 145(6):641-7. PubMed ID: 1893319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.